Introduction: Among female genital tract related malignancies, ovarian tumors are the leading cause of mortality. The present study was conducted to identify the various histopathological spectrums of ovarian neoplasm according to the World Health Organization (WHO) classification in a single center. Objective: To assess the histological patterns of ovarian neoplasm their clinical presentation and age distribution. Methods: It is a retrospective study conducted over a period (Nov 2022-Oct 2024) at Government General Hospital, Kakinada. A total of 200 cases were followed and ovarian specimens are obtained after excluding functional cyst. Data was analysed and tabulated. Results: Out of 200 cases of ovarian tumors, 88.5% cases were benign, 7% cases were borderline, 4.5% cases were malignant. Conclusion: Most of the ovarian tumors benign tumors followed by borderline and then malignant. In this study most common benign tumor is serous cystadenoma. From this study by histopathology, we can differentiate benign from malignant
Ovarian neoplasms are one of the most serious health issues that affect women globally. Ovarian cancer ranks as the third gynecological cancer following cervical and uterine cancers. It has the least favorable prognosis and the highest death rate. The high death rate of ovarian carcinoma is attributed to the silent course of disease, delayed presentation, lack of screening programs which lead to its diagnosis during late stage, there by naming it the silent killer (3)(4).
Ovarian cancer has a wide age of distribution and affects women of all ages but mostly diagnosed between 55 and 64 (2). Familial genetic syndromes have shown to be the strongest risk factors influencing ovarian cancer, accounting for 10-12% of all cases(2)
Other risk factors include (5)
A wide spectrum of ovarian tumors with different histologies could emerge from the ovaries according to the cell of origin, such as(5)
Ovarian tumors cannot be confirmed alone on the basis of clinical, radiological and gross findings. Hence, a precise histopathological diagnosis is required for starting definitive treatment.
AIMS AND OBJECTIVES:
The aim of this study is to determine the histological patterns of ovarian neoplasm, their clinical presentation and age distribution in patients attending GGH, Kakinada.
Type of study: Retrospective study
Study period: From November 2022- October 2024
Duration: 2 years
Sample size: 200 cases
METHOD OF COLLECTION:
All ovarian specimens that are obtained following laparoscopy/laparotomy with or with out hysterectomy are included. History regarding age, parity, presenting complaints like lower abdominal pain, mass per abdomen, menstrual irregularities, postmenopausal bleeding and duration of symptoms are taken. We have planned the type of surgery depending on IOTA classification on USG, tumour markers and CECT abdomen and pelvis/ MRI pelvis.
INLCUSION CRITERIA:
All the histologically proven cases of ovarian tumors were included during given period.
EXCLUSION CRITERIA:
All functional cyst like
All the obtained specimen are grossly examined and sent for histological examination. Data from histopathology reports included specimen source, type of tumor (neoplastic/non- neoplastic) are collected. If found to be neoplastic, data regarding Stage, type, subtype of neoplasm is collected.
A total of 200 cases of ovarian tumors were studied. The clinical presentation, symptoms and ovarian parameters in USG were recorded. After the surgery and excision of ovarian tumour and later by seeing the HPE report, data was analysed and following results were obtained. Out of 200 cases of ovarian tumors, 177 cases were benign, 14 were borderline, 9 were malignant.
According to age group distribution of ovarian tumors:
Most of the patients are from 40-59 years, 74 to be precise followed by 72 cases between 20-39 cases.
AGE |
BENIGN |
BORDERLINE |
MALIGNANT |
<19 years |
9 |
0 |
0 |
20-39 years |
72 |
4 |
1 |
40-59 years |
74 |
6 |
3 |
More than 60 |
22 |
4 |
5 |
Table 1: Distribution of ovarian tumors according to age
Table 2: Distribution of ovarian tumors according to gross appearance:
TYPE OF TUMOR |
SOLID |
CYSTIC |
SOLID-CYSTIC |
Benign |
14 |
135 |
28 |
Borderline |
2 |
10 |
2 |
Malignant |
5 |
0 |
4 |
Clinical presentation of ovarian tumors:
In the present study, most of them were asymptomatic and it is an incidental finding on USG. Abdominal pain was the second most common presenting complaint followed by mass per abdomen.
Table 3: Distribution according to clinical presentation
CLINICAL PRESENTATION |
NO. OF CASES |
PERCENTAGE |
Asymptomatic |
74 |
37% |
Pain abdomen |
56 |
28% |
Mass per abdomen |
40 |
20% |
Irregular cycles |
12 |
6% |
Infertility |
10 |
5% |
Post menopausal bleeding |
8 |
4% |
Types of biopsies received in present study:
Ovarian tissues were received in the form of oophorectomy, staging laparotomy, unilateral or bilateral salpingo-oopherectomy with or without total abdominal hysterectomy.
Table 4: Distribution according to type of biopsy
PROCEDURE DONE |
NO. OF CASES |
PERCENTAGE |
Oopherectomy |
33 |
16.5% |
Staging Laparotomy |
62 |
31% |
TAH+BSO |
90 |
45% |
TAH+USO |
15 |
7.5% |
Table 5: Distribution of the cases according to WHO classification:
EPITHELIAL TUMORS ( SEROUS TUMOR) |
NO.OF CASES 102 |
PERCENTAGE 51% |
Benign |
92 |
90.1% |
Borderline |
7 |
6.8% |
Malignant |
3 |
2.9% |
EPITHELIAL TUMORS ( MUCINOUS TUMOR AND OTHERS) |
NO.OF CASES 81 |
PERCENTAGE 40.5% |
Benign |
75 |
92% |
Borderline |
4 |
4.9% |
Malignant |
2 |
2.4% |
Brenner tumor |
0 |
- |
Endometroid tumor |
0 |
- |
SEX CORD STROMAL TUMOR |
NO.OF CASES |
PERCENTAGE |
Granulosa cell tumor |
2 |
1% |
Fibroma |
2 |
1% |
Thecoma-fibroma |
0 |
- |
GERM CELL TUMOR |
NO.OF CASES |
PERCENTAGE |
Dysgerminoma |
2 |
1% |
Yolk sac tumor |
1 |
0.5% |
Mature cystic teratoma |
10 |
5% |
Immature cystic teratoma |
0 |
- |
The peak incidence of the ovarian tumors in the present study was in the fifth decade (41.5%) which was very much similar to the observations of Valson et al in their study in the year 2017 reported 30.85% cases in 5th decade (1). In the present study most patients were asymptomatic(37%) followed by abdominal pain (28%) . It is similar with studies done by Mankar et al in 2015 (33.48%) and Kanthikar et al (53.33%) where pain in abdomen was the commonest symptom (1). The majority of epithelial tumors were serous tumors accounting 51% then followed by mucinous tumors, accounting for 40.5% of cases. The results were similar to studies done by Abdullah and Bondagji in Saudi and Sawant and Mahajan in India (2) in 2016. Serous cystadenocarcinoma was the most common malignant surface epithelium tumor which was in concordance with the results of Ahmad et al (1) in 2016. When compared with other studies done by Pilli et al in 2002, Jha et al in 2004 and Mankar et al in 2015, the incidence of malignant tumors in our study was low. In present study germ cell tumor were 13(6.5%) in which benign cystic teratoma comprised maximum number of cases 10(5%). Akakpo et al in 2017 reported similar incidence of mature cystic teratoma (93.5%) cases in their study (1).
|
In my study |
Study conducted at Tertiary care hospital, Rajasthan |
Histopathological pattern of ovarian neoplasm in western region of Saudi |
Cross sectional study depicting histopathological features of ovarian tumors |
Age (5th decade) |
41.5% |
24.61% |
39.2% |
24.23% |
Type of tumor(Benign) |
88.5% |
66.92% |
64.4% |
35.63% |
Presentation (Pain abdomen) |
28% |
46.1% |
- |
92.43% |
Distribution(Serous tumor) |
51% |
30.77% |
44.6% |
18.39% |